• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
  • For Subscribers

Trendingnow

1

This 71-year-old cattleman’s farm brings in $30 million a year. He says the cattle cycle that built it is broken 

2

Even FEMA officials are worried about the string of outages and withdrew extra cash — 'This is scary, and there is no leadership'

3

2 years ago, Saudi Arabia quietly canceled the 'petrodollar' deal with America that wired the world economy for 50 years. Then war broke out in Iran

1

This 71-year-old cattleman’s farm brings in $30 million a year. He says the cattle cycle that built it is broken 

2

Even FEMA officials are worried about the string of outages and withdrew extra cash — 'This is scary, and there is no leadership'

3

2 years ago, Saudi Arabia quietly canceled the 'petrodollar' deal with America that wired the world economy for 50 years. Then war broke out in Iran
NewslettersBrainstorm Health

One drug, one patent?

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
January 28, 2020, 8:27 PM ET
Google source logo
Add Fortune on Google for similar content.

This is the web version of Brainstorm Health Daily, Fortune’s daily newsletter on the top health care news. To get it delivered daily to your in-box, sign up here.

Good afternoon, readers.

How should the drug patent system work?

Biopharma executives, unsurprisingly, tend to emphasize the importance of innovation—and regularly argue that strong intellectual property protections are essential to the project of advancing human medicine.

Democratic presidential candidate Michael Bloomberg is taking a different tact, proposing that any new branded pharmaceutical drug should only be able to win one patent.

That would be a massive transformation for the industry if it were to go through. It’s something we need to keep our eyes on.

Read on for the day’s news.

Sy Mukherjee
sayak.mukherjee@fortune.com
@the_sy_guy

DIGITAL HEALTH

The scapegoat. We still don't know how this virus (the coronovirus, that is) progresses. It's a complicated procedure. Any vaccine will take months, if not years, to develop. I wish I had more to add, but the reality is: We just don't know what is going on.

REQUIRED READING

How Bank of America's CEO Orchestrated One of the Biggest Comebacks in Baking History, by Shawn Tully

Why 2020 Is Turning Out to Be a Strong Year for IPOs, by Lucinda Shen

Melinda Gates and her $50 Million Donation, by Maria Aspan

Sign up for other Fortune newsletters.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Newsletters


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Recommended For You

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.